Vice President, Portfolio Management
Mr. Soikes is Vice President of Portfolio Management at Curis. Prior to joining Curis, he served as Global Development Lead at Shire (formerly Baxalta) developing and launching OBIZURTM and myPKFiTTM and in various program management leadership roles at Baxter International. Before that, Mr. Soikes worked at Bristol-Myers Squibb developing and launching ReyatazTM and developing YervoyTM and SprycelTM . Earlier in his career, he held various leadership positions with Vion Pharmaceuticals, Genelabs Diagnostics Pte. Ltd (Singapore), and Genelabs Technologies, Inc. He holds a B.S. in Microbiology and a M.S. in Microbiology with concentration in Immunology and Toxicology, both from San Jose State University.